Velagliflozin proline hydrate
Modify Date: 2024-09-21 13:56:21
Velagliflozin proline hydrate structure
|
Common Name | Velagliflozin proline hydrate | ||
|---|---|---|---|---|
| CAS Number | 1661838-94-3 | Molecular Weight | 528.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H36N2O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Velagliflozin proline hydrateVelagliflozin proline hydrate is the clinical form of Velagliflozin (HY-109018). Velagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations[1]. |
| Name | Velagliflozin proline hydrate |
|---|
| Description | Velagliflozin proline hydrate is the clinical form of Velagliflozin (HY-109018). Velagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations[1]. |
|---|---|
| Related Catalog | |
| Target |
SGLT2 |
| In Vitro | Velagliflozin proline hydrate 是一种钠-葡萄糖共转运蛋白 2 (SGLT2) 抑制剂，具有抗糖尿病活性[1]。 |
| In Vivo | Velagliflozin proline hydrate (1 mg/kg, 口服, 单剂量) 增加胆固醇、白蛋白、β -羟基丁酸 (BHB)、非酯化脂肪酸 (NEFA) 和尿葡萄糖排泄，并降低猫的呼吸交换比率[1]。 Velagliflozin proline hydrate (0.3 mg/kg; 口服; 每天 1 次, 共 18 天) 耐受性良好，可通过降低饮食非结构性碳水化合物 (NSC) 的高胰岛素反应来治疗小马的胰岛素失调和预防椎板炎[2]。 |
| References |
| Molecular Formula | C28H36N2O8 |
|---|---|
| Molecular Weight | 528.59 |